ArticleAsia Pacific allergy2026
Real-world patient's practices in the management of allergic rhinitis in the Philippine setting.
Article in Asia Pacific allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Allergic rhinitis is a prevalent disease and there is a need for local real-world data to create relevant guidelines and care pathways in its management. Objective: The aim was to investigate the health-seeking behavior and practices of Filipinos in managing allergic rhinitis symptoms. Methods: A cross-sectional stratified online survey was conducted among Filipinos with allergic rhinitis symptoms. Stratified sampling, based on age group and region of residence in the Philippines, with proportional allocation, was used to select the respondents of this study. Results: A total of 317 respondents (213 adults and 104 pediatric) were included in the analysis. The majority (61.83%) had moderate-severe intermittent allergic rhinitis. Eighteen percent (18%) had no prior consult with a physician, while 37% had self-medicated. Sixty-three percent of participants preferred taking prescribed oral medications and 48.6% preferred a prescribed nasal spray. The most common drug classes used for allergic rhinitis were oral antihistamines (68.14%) and steroid nasal spray (34.07%). Only 45.42% admitted to being fully adherent with their prescribed medications. The most frequently cited factors that would improve compliance were cost (47.32%), few side effects (47.32%), and rapid onset of effect (40.38%). Only 21.14% of respondents had undergone allergen skin testing and 6.62% had undergone immunotherapy. Conclusions: Many Filipinos who suffer from allergic rhinitis symptoms have not been seen by a physician or, even after consultation, are not adherent to prescribed medications. There is a need for increased public awareness regarding allergic rhinitis and more effective communication between patients and the healthcare provider to improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.